Cyril Allouche - Net Worth and Insider Trading
Cyril Allouche Net Worth
The estimated net worth of Cyril Allouche is at least $26,432 dollars as of 2024-11-13. Cyril Allouche is the Principal Accounting Officer of Revance Therapeutics Inc and owns about 6,400 shares of Revance Therapeutics Inc (RVNC) stock worth over $26,432. Details can be seen in Cyril Allouche's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cyril Allouche has not made any transactions after 2019-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cyril Allouche
Cyril Allouche Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cyril Allouche owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of Cyril Allouche’s form 4 insider trades.
Insider Ownership Summary of Cyril Allouche
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2019-03-18 | Principal Financial Officer |
Cyril Allouche Latest Holdings Summary
Cyril Allouche currently owns a total of 1 stock. Cyril Allouche owns 6,400 shares of Revance Therapeutics Inc (RVNC) as of March 18, 2019, with a value of $26,432.
Latest Holdings of Cyril Allouche
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2019-03-18 | 6,400 | 4.13 | 26,432 |
Holding Weightings of Cyril Allouche
Cyril Allouche Form 4 Trading Tracker
According to the SEC Form 4 filings, Cyril Allouche has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 498 shares on March 18, 2019, which brought Cyril Allouche around $7,709.
Insider Trading History of Cyril Allouche
- 1
Cyril Allouche Trading Performance
Cyril Allouche Ownership Network
Ownership Network List of Cyril Allouche
Ownership Network Relation of Cyril Allouche
Cyril Allouche Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Cyril Allouche is the Principal Financial Officer of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Cyril Allouche made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 35,664 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Cyril Allouche Mailing Address
Above is the net worth, insider trading, and ownership report for Cyril Allouche. You might contact Cyril Allouche via mailing address: 7555 Gateway Blvd., Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
